| Identification | |
| Name: | 5-Azaspiro[2.5]octane-5-carboxylicacid, 7-[(hydroxyamino)carbonyl]-6-[(4-phenyl-1-piperazinyl)carbonyl]-, methylester, (6S,7S)- |
| Synonyms: | Aderbasib;INCB 007839 |
| CAS: | 791828-58-5 |
| Molecular Formula: | C21H28 N4 O5 |
| Molecular Weight: | 416.47 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.38g/cm3 |
| Specification: |
?Aderbasib , its cas register number is 791828-58-5. It also can be called (6S,7S)-7-[(Hydroxyamino)carbonyl]-6-[(4-phenyl-1-piperazinyl)carbonyl]-5-azaspiro[2.5]octane-5-carboxylic acid methyl ester ; 5-Azaspiro[2.5]octane-5-carboxylicacid, 7-[(hydroxyamino)carbonyl]-6-[(4-phenyl-1-piperazinyl)carbonyl]-, methylester, (6S,7S)- . |
| Usage: | Aderbasib is a azaspiro[2.5]octanehydroxamide derivative as inhibitor of metalloproteases for the treatment of disorders such as cancer, arthritis, cardiovascular or skin disorders. |
| Safety Data | |
 |
|
